Targeting KRAS-mutant tumors with indirect targeting of related pathways yields hope in solid tumors
Oregon Health & Sciences University,
Gordon Mills, M.D., Ph.D., discusses the efficacy of drug combinations for treating KRAS mutations. He says, “Co-mutations…